Solutions to the discrepancies in the extent of liver damage following ischemia/reperfusion in standard mouse models  Rowan F. van Golen, Megan J. Reiniers,

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 36, Issue 12, Pages (December 2016)
Hepatitis C viral proteins perturb metabolic liver zonation
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Tiny RNA with great effects: miR-155 in alcoholic liver disease
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
In Situ Hypothermic Perfusion with Retrograde Outflow During Right Hemihepatectomy: First Experiences with a New Technique  Megan J. Reiniers, MS, Rowan.
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Determinants of hepatic effector CD8+ T cell dynamics
Living donor liver transplantation: is the hype over?
Volume 42, Issue 4, Pages (April 2005)
Reply to: “DCD consensus and futility in liver transplantation”
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 23, Issue 3, Pages (September 2016)
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Volume 44, Issue 4, Pages (April 2006)
New imaging techniques for liver diseases
Volume 44, Issue 2, Pages (February 2006)
Hepatitis C core protein – The “core” of immune deception?
Volume 42, Issue 4, Pages (April 2005)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Volume 75, Issue 2, Pages (January 2009)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Joseph M. Johnson, William J. Betz  Biophysical Journal 
Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish  Chuan Yan, Xiaojing Huo, Shu Wang,
Volume 44, Issue 1, Pages (January 2006)
Volume 29, Issue 4, Pages (April 2016)
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 44, Issue 4, Pages (April 2006)
Volume 123, Issue 6, Pages (December 2005)
Increasing Sensitivity of Ca2+ Spark Detection in Noisy Images by Application of a Matched-Filter Object Detection Algorithm  Cherrie H.T. Kong, Christian.
Autophagy in proximal tubules protects against acute kidney injury
JNK mediates hepatic ischemia reperfusion injury
Volume 62, Issue 1, Pages (January 2015)
Pharmacologic attenuation of the hyperdynamic response to supraceliac aortic clamping  Marlin Wayne Causey, MD, Seth Miller, MD, Niten Singh, MD, Matthew.
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 44, Issue 2, Pages (February 2006)
Volume 60, Issue 1, Pages (January 2014)
Nobuhiko Takahashi, Yong Qi, Hiral R. Patel, Rexford S. Ahima 
Julie Parkes, Indra Neil Guha, Paul Roderick, William Rosenberg 
Xiangqing Sun, Robert Elston, Nathan Morris, Xiaofeng Zhu 
Volume 64, Issue 5, Pages (May 2016)
Volume 48, Issue 6, Pages (December 2005)
Volume 136, Issue 3, Pages e2 (March 2009)
Attenuation of high-frequency (30–200 Hz) thalamocortical EEG rhythms as correlate of anaesthetic action: evidence from dexmedetomidine  G. Plourde, F.
Ischemic and non-ischemic acute kidney injury cause hepatic damage
Volume 65, Issue 2, Pages (August 2016)
Hepatology may have problems with putative surrogate outcome measures
A Scalable Population Code for Time in the Striatum
N. Männicke, M. Schöne, M. Oelze, K. Raum  Osteoarthritis and Cartilage 
Volume 50, Issue 3, Pages (March 2009)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Serum HBV pgRNA as a clinical marker for cccDNA activity
Volume 62, Issue 3, Pages (March 2015)
Volume 61, Issue 2, Pages (August 2014)
Volume 60, Issue 1, Pages (January 2014)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 71, Issue 1, Pages (July 2019)
Genetics of hepatocellular carcinoma: The next generation
Volume 70, Issue 5, Pages (May 2019)
Use Dependence of Heat Sensitivity of Vanilloid Receptor TRPV2
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Presentation transcript:

Solutions to the discrepancies in the extent of liver damage following ischemia/reperfusion in standard mouse models  Rowan F. van Golen, Megan J. Reiniers, Michal Heger  Journal of Hepatology  Volume 62, Issue 4, Pages 975-977 (April 2015) DOI: 10.1016/j.jhep.2014.12.014 Copyright © 2014 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Characterization of mouse models of liver ischemia/reperfusion injury. Plasma ALT levels (mean±SD) plotted as a function of liver ischemia time, measured after (A) 6h or (B) 24h of reperfusion. Data are obtained from I/R experiments in male C57BL/6J mice subjected to 20–90min of partial (70%) liver ischemia or a sham operation (n=4–13/group, total of 89 animals). The five-parameter logistic curve fits (black lines) show a goodness-of-fit (R2) of 0.9028 and 0.9051 for the (A) 6-h and (B) 24-h reperfusion ALT data, respectively, which corresponds to a mean half-maximum-effect (logEC50) ischemia time of 34min. Panels (C) and (D) show the (estimated) ALT values (y-axis, log2 scale) extracted from all publications reporting the use of a mouse model of hepatic I/R in the last 5years (see Supplementary Table 1) as a function of ischemia time (60 and 90min, x-axis). The ALT values were measured after (C) 6h or (D) 24h of reperfusion. Only data from experiments performed with wild type mice without parenchymal liver disease were used to compile this Figure and Supplementary Table 1. The red dots represent our own data. Panels (E–J) are typical histological images obtained after 20–90min of ischemia or sham operation and 24h of reperfusion. The percentage of confluent parenchymal necrosis and corresponding plasma ALT levels are shown at the top of each panel. Confluent parenchymal necrosis was scored in a blinded fashion by J.V. using the following scoring system: 0=0%, 1<25%, 2=25–50%, 3=50–75%, 4>75%. The values between brackets indicate the range. The duration of ischemia is shown in the bottom right of each panel. Areas of viable hepatocytes are encircled in white (dashed line). In line with earlier reports [9,10], (morphological) signs of apoptosis were not evident in our experiments. Panels (K) and (L) depict the correlation between plasma ALT concentrations and the extent of hepatocellular necrosis in our mouse model after 6h and 24h reperfusion, respectively. The Spearman correlation coefficient (r) is shown at the bottom right. Detailed protocols for the abovementioned experiments and an extensive literature overview of mouse hepatic I/R injury models from the last 5years are provided in the Supplementary material. (This figure appears in colour on the web.) Journal of Hepatology 2015 62, 975-977DOI: (10.1016/j.jhep.2014.12.014) Copyright © 2014 European Association for the Study of the Liver Terms and Conditions